The association between the survivin −31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population
Authors:
- Süleyman BayramSBSüleyman Bayram
- Hikmet AkkızHAHikmet Akkız
- Aynur BekarABAynur Bekar
- Ersin AkgöllüEAErsin Akgöllü
- 1 December 2011
- journal article
- Published by Elsevier in Cancer Epidemiology
- Vol. 35 (6) , 555-559
Abstract
No abstract availableKeywords
Funding Information
- Çukurova Üniversitesi
This publication has 31 references indexed in Scilit:
- Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: Case–control studyCancer Epidemiology, 2010
- Dysregulation of apoptosis in hepatocellular carcinoma cellsWorld Journal of Gastroenterology, 2009
- Apoptotic Pathways in Tumor Progression and Therapy2008
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- Structural, functional and therapeutic biology of survivinCancer Letters, 2006
- Hepatocellular carcinoma pathogenesis: from genes to environmentNature Reviews Cancer, 2006
- Role of the SurvivinGene in PathophysiologyThe American Journal of Pathology, 2006
- Biomarkers in Cancer Staging, Prognosis and Treatment SelectionNature Reviews Cancer, 2005
- Survivin promotes cell proliferation in human hepatocellular carcinomaHepatology, 2000
- Control of apoptosis and mitotic spindle checkpoint by survivinNature, 1998